Giuseppe Curigliano, MD, PhD
European Institute of Oncology
Giuseppe Curigliano is associate professor of medical oncology at the University of Milan and head of the division of early drug development at European Institute of Oncology in Milan, Italy. Professor Curigliano is a clinician and researcher specialising in early drug development for patients with solid tumours with a special commitment on breast cancer.
Professor Curigliano has been a member of the European Society for Medical Oncology (ESMO) Breast Cancer Faculty since 2001 and is currently the faculty coordinator. Since 2011, he has served on the Scientific Committee for the St Gallen Conference, and was the scientific chair in St Gallen 2017. Professor Curigliano has been an editorial board member for Annals of Oncology since 2014, and serves as co-editor in chief of The Breast and of Cancer Treatment Reviews, associate editor of the European Journal of Cancer and editor of the Journal of Clinical Oncology. He is also a member of the European School of Oncology (ESO) Faculty Committee.
Professor Curigliano serves ESMO as a council member and chair of the Nomination Committee. Since 2016, he has also been a member of the ESMO Women for Oncology Committee, ESMO Membership Committee, ESMO Press and Media Affairs Committee, and the ESMO Global Policy Committee. Professor Curigliano served as the scientific chair of the IMPAKT meeting in Brussels in 2014 and as the breast cancer (metastatic) track chair of the ESMO 2014 meeting in Madrid. He was co-chair for the first ESMO Breast Cancer Congress in 2019.
Professor Curigliano was awarded the first ESO Umberto Veronesi Award in Vienna and the Fellowship of the European Academy of Cancer Sciences (EACS) in Paris in 2017. He has contributed to over 290 peer-reviewed publications.